Non-coding RNA Neat1 and Abhd11os expressions are dysregulated in medium spiny neurons of Huntington disease model mice.

Park H, Miyazaki H, Yamanaka T, Nukina N.

Neurosci Res. 2019 Oct;147:58-63. doi: 10.1016/j.neures.2018.10.013. Epub 2018 Nov 2.

Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington's disease patients.

Ramirez-Garcia G, Galvez V, Diaz R, Bayliss L, Fernandez-Ruiz J, Campos-Romo A.

Eur J Neurosci. 2019 Nov 9. doi: 10.1111/ejn.14617. [Epub ahead of print]

Cytotoxicity models of Huntington's disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies.

Calabrese EJ, Bhatia TN, Calabrese V, Dhawan G, Giordano J, Hanekamp YN, Kapoor R, Kozumbo WJ, Leak RK.

Pharmacol Res. 2019 Dec;150:104371. doi: 10.1016/j.phrs.2019.104371. Epub 2019 Aug 12. Review.

Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings.

Zhang Y, Ren R, Yang L, Zhou J, Li Y, Shi J, Lu L, Sanford LD, Tang X.

Sleep. 2019 Oct 9;42(10). pii: zsz154. doi: 10.1093/sleep/zsz154.

Generation of 5 induced pluripotent stem cell lines, LUMCi007-A and B and LUMCi008-A, B and C, from 2 patients with Huntington disease.

van der Graaf LM, Gardiner SL, Tok M, Brands T, Boogaard MW, Pepers BA, Eussen B, de Klein A, Aziz NA, Freund C, Buijsen RAM, van Roon-Mom WMC.

Stem Cell Res. 2019 Aug;39:101498. doi: 10.1016/j.scr.2019.101498. Epub 2019 Jul 12.

Assessment of the Performance of a Modified Motor Scale as Applied to Juvenile Onset Huntington's Disease.

Horton MC, Nopoulos P, Nance M, Landwehrmyer GB, Barker RA, Squitieri F; REGISTRY Investigators of the European Huntington’s Disease Network., Burgunder JM, Quarrell O.

J Huntingtons Dis. 2019 Mar 7. doi: 10.3233/JHD-180306. [Epub ahead of print]

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?

Migliore S, Jankovic J, Squitieri F.

Front Neurol. 2019 Apr 30;10:453. doi: 10.3389/fneur.2019.00453. eCollection 2019.

CTIP2-Regulated Reduction in PKA-Dependent DARPP32 Phosphorylation in Human Medium Spiny Neurons: Implications for Huntington Disease.

Fjodorova M, Louessard M, Li Z, De La Fuente DC, Dyke E, Brooks SP, Perrier AL, Li M.

Stem Cell Reports. 2019 Sep 10;13(3):448-457. doi: 10.1016/j.stemcr.2019.07.015. Epub 2019 Aug 22.

Late-onset Huntington's disease with 40-42 CAG expansion.

Capiluppi E, Romano L, Rebora P, Nanetti L, Castaldo A, Gellera C, Mariotti C, Macerollo A, Cislaghi MG.

Neurol Sci. 2019 Dec 9. doi: 10.1007/s10072-019-04177-8. [Epub ahead of print]

Brain compensation during visuospatial working memory in premanifest Huntington's disease.

Soloveva MV, Jamadar SD, Velakoulis D, Poudel G, Georgiou-Karistianis N.

Neuropsychologia. 2020 Jan;136:107262. doi: 10.1016/j.neuropsychologia.2019.107262. Epub 2019 Nov 14.

Enriched chitosan nanoparticles loaded with siRNA are effective in lowering Huntington's disease gene expression following intranasal administration.

Sava V, Fihurka O, Khvorova A, Sanchez-Ramos J.

Nanomedicine. 2019 Oct 27:102119. doi: 10.1016/j.nano.2019.102119. [Epub ahead of print]

Multimodal characterization of the visual network in Huntington's disease gene carriers.

Gregory S, Odish OFF, Mayer I, Mills J, Johnson EB, Scahill RI, Rothwell J, Rees G, Long JD, Tabrizi SJ, Roos RAC, Orth M.

Clin Neurophysiol. 2019 Nov;130(11):2053-2059. doi: 10.1016/j.clinph.2019.08.018. Epub 2019 Aug 28.

The caudate nucleus undergoes dramatic and unique transcriptional changes in human prodromal Huntington's disease brain.

Agus F, Crespo D, Myers RH, Labadorf A.

BMC Med Genomics. 2019 Oct 16;12(1):137. doi: 10.1186/s12920-019-0581-9.

Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene.

Franich NR, Hickey MA, Zhu C, Osborne GF, Ali N, Chu T, Bove NH, Lemesre V, Lerner RP, Zeitlin SO, Howland D, Neueder A, Landles C, Bates GP, Chesselet MF.

J Neurosci Res. 2019 Dec;97(12):1590-1605. doi: 10.1002/jnr.24493. Epub 2019 Jul 7.

Brain Zinc Deficiency Exacerbates Cognitive Decline in the R6/1 Model of Huntington's Disease.

Ayton S, Lei P, Appukuttan AT, Renoir T, Foliaki S, Chen F, Adlard PA, Hannan AJ, Bush AI.

Neurotherapeutics. 2020 Jan;17(1):243-251. doi: 10.1007/s13311-019-00785-6.